Literature DB >> 24296766

The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.

Stephan Walrand1, Michel Hesse, Carlo Chiesa, Renaud Lhommel, Francois Jamar.   

Abstract

UNLABELLED: (90)Y resin and glass microsphere liver radioembolizations delivering lobar doses of 70 and 120 Gy, respectively, display hepatic toxicity similar to 40-Gy fractionated external-beam radiotherapy. We investigated how the lower number of glass microspheres could induce a sufficiently nonuniform dose distribution explaining this paradox.
METHODS: Microscale dosimetry was assessed in the realistic liver model developed by Gulec et al. but using the Russell's dose deposition kernel. A lattice of hexagonal prisms represented the hepatic lobules. Two hepatic arterial tree models-that is, a fixed-length and a variable-branches length-were used for the microsphere transport. Equal or asymmetric microsphere relative-spreading probability between 2 daughter vessels was assumed. Several 120-Gy liver simulations were performed: periodic simulations, where 1 or 6 glass microspheres were trapped in all and in only 1 of 6 portal tracts, respectively, and random simulations, where glass microsphere trapping assumed an equal probability for all the portal tracts or a variable probability depending on the successions of artery connections leading to the portal tract, both for the 2 arterial tree models.
RESULTS: For the 2 uniform simulations, all hepatic structures received at least 100 Gy. The fast decrease of the (90)Y kernel as the inverse of the square of the distance r is counterbalanced by the number of contributing lobules containing microspheres that increases as r(2). The random simulation with equal-spreading probability gave for the less irradiated tissue a lobule dose distribution centered around 103 Gy (full width at half maximum, 20 Gy). The distribution became significantly asymmetric with the 60%-40% relative-spreading probability, with a shift of the maximum from 103 down to 50 Gy, and about 17% of the lobules got a dose lower than 40 Gy to their different structures.
CONCLUSION: The large nonuniform trapping produced by the microsphere transport in the arterial tree jointly with the low number of injected glass microspheres begins to explain their lower hepatic toxicity per Gray. In addition, the nonuniform trapping supports the fact that the granular aspect of (90)Y PET imaging observed in patients could represent some reality and not only statistical noise.

Entities:  

Keywords:  90Y PET imaging; dosimetry; hepatic toxicity; liver radioembolization; microsphere transport modeling

Mesh:

Substances:

Year:  2013        PMID: 24296766     DOI: 10.2967/jnumed.113.126839

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  27 in total

1.  Radioembolization with (90)Y-loaded microspheres: high clinical impact of treatment simulation with MAA-based dosimetry.

Authors:  Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07       Impact factor: 9.236

Review 2.  Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.

Authors:  Alexander Villalobos; Mohamed M Soliman; Bill S Majdalany; David M Schuster; James Galt; Zachary L Bercu; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

3.  The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).

Authors:  Carlo Spreafico; Marco Maccauro; Vincenzo Mazzaferro; Carlo Chiesa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04       Impact factor: 9.236

4.  Personalized Dosimetry for Liver Cancer Y-90 Radioembolization Using Computational Fluid Dynamics and Monte Carlo Simulation.

Authors:  Emilie Roncali; Amirtahà Taebi; Cameron Foster; Catherine Tram Vu
Journal:  Ann Biomed Eng       Date:  2020-01-31       Impact factor: 3.934

5.  Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

Authors:  C Chiesa; M Mira; M Maccauro; C Spreafico; R Romito; C Morosi; T Camerini; M Carrara; S Pellizzari; A Negri; G Aliberti; C Sposito; S Bhoori; A Facciorusso; E Civelli; R Lanocita; B Padovano; M Migliorisi; M C De Nile; E Seregni; A Marchianò; F Crippa; V Mazzaferro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-27       Impact factor: 9.236

6.  Development of a Customizable Hepatic Arterial Tree and Particle Transport Model for Use in Treatment Planning.

Authors:  Nathan R Crookston; George S K Fung; Eric C Frey
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-05-31

7.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

8.  The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure.

Authors:  Alexander S Pasciak; Godwin Abiola; Robert P Liddell; Nathan Crookston; Sepideh Besharati; Danielle Donahue; Richard E Thompson; Eric Frey; Robert A Anders; Matthew R Dreher; Clifford R Weiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

9.  The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure.

Authors:  Altan Ahmed; John A Stauffer; Jordan D LeGout; Justin Burns; Kristopher Croome; Ricardo Paz-Fumagalli; Gregory Frey; Beau Toskich
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 10.  Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects.

Authors:  Philippe d'Abadie; Michel Hesse; Amandine Louppe; Renaud Lhommel; Stephan Walrand; Francois Jamar
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.